CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock Class A Common Stock	Common Stock Class V Common Stock	Accumulated Deficit	Accumulated Other Comprehensive Loss	Treasury Stock	Total Stockholders' Deficit Attributable to biote Corp.	Non Controlling Interest
Beginning balance at Dec. 31, 2022	$ (58,274)	$ 1	$ 5	$ (44,460)	$ (5)		$ (44,459)	$ (13,815)
Beginning balance, shares at Dec. 31, 2022		9,655,387	48,565,824
Distributions	(3,093)							(3,093)
Net Loss	(21,430)			(6,805)			(6,805)	(14,625)
Other comprehensive income (loss)	1							1
Share-based compensation	2,170			2,170			2,170
Vesting of RSUs				1,915	(4)		1,911	(1,911)
Vesting of RSUs, shares		426,208
Exercise of stock options	420			2,043	(3)		2,040	(1,620)
Exercise of stock options, shares		105,049
Litigation settlement	1,199			1,199			1,199
Litigation settlement, shares		375,000
Exchanges of Class V voting stock		$ 1	$ (1)	208			208	(208)
Exchanges of Class V voting stock, shares		7,953,258	(7,953,258)
TRA liability	(4,802)			(4,802)			(4,802)
Ending balance at Mar. 31, 2023	(83,809)	$ 2	$ 4	(48,532)	(12)		(48,538)	(35,271)
Ending balance, shares at Mar. 31, 2023		18,514,902	40,612,566
Beginning balance at Dec. 31, 2022	(58,274)	$ 1	$ 5	(44,460)	(5)		(44,459)	(13,815)
Beginning balance, shares at Dec. 31, 2022		9,655,387	48,565,824
Net Loss	(34,525)
Ending balance at Jun. 30, 2023	(73,238)	$ 3	$ 3	(46,393)	(18)		(46,405)	(26,833)
Ending balance, shares at Jun. 30, 2023		27,723,136	34,819,066
Beginning balance at Dec. 31, 2022	(58,274)	$ 1	$ 5	(44,460)	(5)		(44,459)	(13,815)
Beginning balance, shares at Dec. 31, 2022		9,655,387	48,565,824
Ending balance at Dec. 31, 2023	(36,546)	$ 3	$ 3	(29,391)	(12)		(29,397)	(7,149)
Ending balance, shares at Dec. 31, 2023		34,254,883	28,819,066
Beginning balance at Mar. 31, 2023	(83,809)	$ 2	$ 4	(48,532)	(12)		(48,538)	(35,271)
Beginning balance, shares at Mar. 31, 2023		18,514,902	40,612,566
Distributions	(3,495)							(3,495)
Net Loss	(13,095)			(5,143)			(5,143)	(7,952)
Other comprehensive income (loss)	(1)							(1)
Share-based compensation	2,647			2,647			2,647
Vesting of RSUs				(3,932)	(1)		(3,933)	3,933
Vesting of RSUs, shares		326,261
Settlement of warrants	17,515			15,986	(1)		15,985	1,530
Settlement of warrants, Shares		3,088,473
Exchanges of Class V voting stock		$ 1	$ (1)	(14,419)	(4)		(14,423)	14,423
Exchanges of Class V voting stock, shares		5,793,500	(5,793,500)
TRA liability	(7,000)			(7,000)			(7,000)
Ending balance at Jun. 30, 2023	(73,238)	$ 3	$ 3	(46,393)	(18)		(46,405)	(26,833)
Ending balance, shares at Jun. 30, 2023		27,723,136	34,819,066
Beginning balance at Dec. 31, 2023	(36,546)	$ 3	$ 3	(29,391)	(12)		(29,397)	(7,149)
Beginning balance, shares at Dec. 31, 2023		34,254,883	28,819,066
Distributions	(2,112)							(2,112)
Net Loss	(5,810)			(2,070)			(2,070)	(3,740)
Other comprehensive income (loss)	(5)				(2)		(2)	(3)
Share-based compensation	1,763			1,763			1,763
Vesting of RSUs				(155)			(155)	155
Vesting of RSUs, shares		177,843
Exercise of stock options	324			(1,831)			(1,831)	2,155
Exercise of stock options, shares		80,598
Common stock repurchased	(4,088)					$ (4,088)	(4,088)
Common stock repurchased, shares		(740,921)
Shares issued in connection with acquisition	1,574			381			381	1,193
Shares issued in connection with acquisition, share		291,829
Ending balance at Mar. 31, 2024	(44,900)	$ 3	$ 3	(31,303)	(14)	(4,088)	(35,399)	(9,501)
Ending balance, shares at Mar. 31, 2024		34,064,232	28,819,066
Beginning balance at Dec. 31, 2023	(36,546)	$ 3	$ 3	(29,391)	(12)		(29,397)	(7,149)
Beginning balance, shares at Dec. 31, 2023		34,254,883	28,819,066
Net Loss	(16,285)
Ending balance at Jun. 30, 2024	(141,651)	$ 3	$ 1	(137,723)	(22)	(5,600)	(143,341)	1,690
Ending balance, shares at Jun. 30, 2024		30,993,898	5,221,653
Beginning balance at Mar. 31, 2024	(44,900)	$ 3	$ 3	(31,303)	(14)	(4,088)	(35,399)	(9,501)
Beginning balance, shares at Mar. 31, 2024		34,064,232	28,819,066
Distributions	(2,091)							(2,091)
Net Loss	(10,475)			(6,322)			(6,322)	(4,153)
Other comprehensive income (loss)	(3)				(3)		(3)
Share-based compensation	2,841			2,841			2,841
Vesting of RSUs				(19,536)	(7)		(19,543)	19,543
Vesting of RSUs, shares		215,190
Issuance of shares under SEPA	146			(812)			(812)	958
Issuance of shares under SEPA, shares		35,698
Exercise of stock options	238			(2,827)	(1)		(2,828)	3,066
Exercise of stock options, shares		63,503
Common stock repurchased	(1,511)					(1,511)	(1,511)
Common stock repurchased, shares		(256,043)
Shares issued in connection with acquisition	267			267			267
Exchanges of Class V voting stock				4,022	2		4,024	(4,024)
Exchanges of Class V voting stock, shares		1,946,408	(1,946,408)
Legal Settlement - Repurchase of Shares, Shares		(5,075,090)	(21,651,005)
Legal Settlement - Repurchase of Shares	(128,416)		$ (2)	(126,306)	1	(1)	(126,308)	(2,108)
Legal Settlement - Liabilities	41,424			41,424			41,424
TRA liability	829			829			829
Ending balance at Jun. 30, 2024	$ (141,651)	$ 3	$ 1	$ (137,723)	$ (22)	$ (5,600)	$ (143,341)	$ 1,690
Ending balance, shares at Jun. 30, 2024		30,993,898	5,221,653